Spire Healthcare Group plc (LON:SPI) Plans Dividend of GBX 2.30

Spire Healthcare Group plc (LON:SPI - Get Free Report) declared a dividend on Thursday, March 6th, DividendData.Co.Uk reports. Shareholders of record on Thursday, May 22nd will be given a dividend of GBX 2.30 ($0.03) per share on Friday, June 20th. This represents a yield of 1.29%. The ex-dividend date of this dividend is Thursday, May 22nd. This is a 9.5% increase from Spire Healthcare Group's previous dividend of $2.10. The official announcement can be accessed at this link.

Spire Healthcare Group Price Performance

LON:SPI opened at GBX 197.80 ($2.64) on Tuesday. The firm has a market capitalization of £794.30 million, a price-to-earnings ratio of 28.15, a PEG ratio of 1.06 and a beta of 0.96. Spire Healthcare Group has a 1 year low of GBX 168.20 ($2.25) and a 1 year high of GBX 270.50 ($3.61). The business has a 50 day simple moving average of GBX 185.44 and a 200-day simple moving average of GBX 209.93. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.12) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Equities analysts forecast that Spire Healthcare Group will post 15.6634747 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft decreased their price target on Spire Healthcare Group from GBX 320 ($4.27) to GBX 300 ($4.01) and set a "buy" rating for the company in a research note on Thursday, March 6th.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.